CLDX
Celldex Therapeutics Inc
31.10$
-7.1%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 1996 | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -881.8% | -641.7% | -404.5% | -575.6% | -580.7% | -622.4% | -248.5% | -253.4% | -150.9% | -194.8% | 547.6% | -378.3% | 245.2% | -196.8% | -64.9% | -384.9% | -444.4% | -1,646.0% | -2,831.5% | -1,804.5% | -1,665.7% | -784.2% | -788.8% | -1,299.0% | -544.7% | -1,309.6% | -4,401.0% | -1,558.8% | -2,247.5% | -14,063.0% | |
| 45.5% | 33.3% | 45.5% | 134.0% | 171.8% | 67.5% | 24.2% | 33.0% | 25.0% | 69.0% | 42.5% | 52.7% | 34.0% | 23.3% | 12.5% | 44.9% | 28.0% | 71.6% | 94.8% | 73.2% | 60.3% | 41.7% | 39.9% | 136.0% | 53.0% | 66.0% | 59.4% | 43.7% | 45.3% | -165.0% | |
| – | – | – | – | – | – | – | 2,482.2% | 4,782.3% | 17,420.4% | 32,989.7% | 7,045.8% | 64,592.4% | 20.1% | 6.0% | 25.3% | 20.5% | 110.6% | 191.1% | 233.1% | 225.7% | 96.6% | 84.7% | 127.4% | 52.8% | 192.5% | 662.3% | 347.1% | 487.8% | 2,414.5% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 24.7% | 19.8% | 110.1% | 190.9% | 233.1% | 226.9% | 2.2% | 928.6% | 141.8% | 212.3% | 163.1% | 407.1% | – | – | – | |
| -72.7% | -16.7% | -127.3% | 45.5% | 936.9% | -12.5% | -66.4% | -38.3% | 16.6% | 322.2% | 885.5% | -26.4% | 581.3% | 6.2% | -79.4% | 25.5% | 39.5% | 186.8% | 170.9% | 198.7% | -96.7% | -95.8% | -161.2% | -121.0% | -4.0% | -22.7% | -165.4% | 195.6% | -307.7% | 937.2% | |
| 54.5% | 8.3% | 13.6% | 46.4% | 23.2% | 18.1% | 8.5% | 4.5% | 0.1% | 0.0% | 189.1% | 97.5% | 17.5% | 3.5% | 4.5% | 5.5% | 2.7% | 102.6% | 53.8% | 89.0% | 40.5% | 14.0% | 8.5% | 20.5% | 20.9% | 26.9% | 77.6% | 26.4% | 27.3% | 180.9% | |
| -18.2% | 125.0% | 345.5% | 220.3% | -126.6% | -23.2% | -12.5% | -47.7% | -24.2% | -70.4% | -188.8% | -111.9% | 136.2% | 297.0% | -34.5% | -23.3% | -151.6% | -1,883.3% | -1,143.6% | -915.9% | 1,015.4% | 364.7% | 312.6% | 478.0% | -1,324.0% | -4,647.5% | 3,816.0% | -1,536.9% | -4,132.9% | 13,938.1% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | -2.0% | -2.0% | – | – | – | – | – | – | – | 388.8% | 747.9% | 7,192.8% | 32.7% | 3,524.7% | 213.4% | 402.5% | 308.7% | 455.0% | 2,308.3% | 5,856.2% | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -81.9% | -35.9% | -279.8% | – | – | – | – | – | – | – | 0.0% | 0.0% | – | – | – | |
| 927.3% | – | 168.2% | 670.9% | 5,497.4% | 421.1% | -1.4% | 197.1% | 371.7% | -4.3% | -4.0% | -4.7% | 146.5% | -16.2% | 23.1% | 306.9% | 712.0% | 7,044.5% | 32.7% | 3,524.7% | 213.4% | 402.5% | 308.7% | 455.0% | 2,308.3% | 5,856.2% | 172.9% | 3,173.9% | 6,288.4% | 159.2% | |
| 27.3% | -516.7% | 113.6% | 315.6% | 4,790.1% | -224.5% | -262.4% | -104.0% | 196.7% | -269.5% | 354.7% | -494.9% | 527.8% | 84.0% | -76.3% | -101.3% | 116.0% | 3,515.1% | -3,942.6% | 804.5% | -436.9% | -17.1% | -167.5% | -366.0% | 439.5% | -100.9% | -412.1% | 78.2% | -92.0% | 34.3% | |
| -936.4% | -650.0% | -418.2% | -622.0% | -603.9% | -640.5% | -256.9% | -257.9% | -150.8% | -194.8% | 358.5% | -475.8% | 227.7% | -200.2% | -69.4% | -390.4% | -447.1% | -1,748.7% | -2,885.3% | -1,893.5% | -1,706.3% | -798.2% | -797.3% | -1,319.5% | -565.6% | -1,336.4% | -4,478.6% | -1,585.2% | -2,274.9% | -14,243.9% |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.